Primary preventive interventions on traffic accidents among males: A review on the literature during 2009-2019 in Iran

Introduction: The present study aimed to compare the national health indicators and the effectiveness of primary preventive interventions on traffic accidents in Iran during the last decade (2009-2019). Methods: All published original articles on the primary preventive intervention and health indicators of traffic accidents in Iran were extracted. The inclusion criteria included epidemiologic studies on Iranian male population during 2009-2019. Data were screened and extracted by two independent evaluators and the quality of studies was checked using the STROBE checklist. The exclusion criteria included those articles aimed at presenting results of second or third levels prevention (including injury management, pre-hospital emergency management, economic analyses, case reports, and traffic accidents from non-human perspectives).  Accident-related mortality rates, proportionate mortality from traffic accidents per 1000 vehicles, and per 1000 accidents were estimated.  Results: A total of 65 original articles were included of which 13 were presented health indicators. The crude mortality rate varied from 57.1 in Sistan-Balooshestan province to 73 (per 100,000 population ) in Fars province.  The age-standardized mortality rate among male pedestrians (per 100,000 population) varied from 10.6-33.4 in Gilan and Mazandaran, 42 in Fars, 50.9 in Lorestan provinces. During the last 10 years, the mortality rate decreased from 38 to 12 cases per 1000 vehicles and increased from 51 to 56 cases per 100 accidents. Studies on the effectiveness of primary level prevention have addressed regulations on controlling blood alcohol level and international projection models.  Conclusions: The type of health indicators related to traffic accidents seems to vary greatly among studies. Investigation on the effectiveness of primary preventive interventions on traffic caccidents are proposed frequently by WHO. Nevertheless, short-term and long-term effectiveness of many interventions including educational packages, regulations and specific laws have not been assessed in Iran

The Effect of Percutaneous Laser Disc Decompression on Reducing Pain and Disability in Patients With Lumbar Disc Herniation

Introduction: As low back pain incidence is increasing, noninvasive modalities are gaining attention for their ability to achieve the best possible outcome with the least complications. Percutaneous laser disc decompression (PLDD) is currently popular for this purpose. This study aims to evaluate the effect of PLDD on disability and pain reduction in patients with lumbar disc herniation.Methods: Thirty patients were enrolled in this study. Spinal nerve blocks were conducted by laser discectomy single stage injection of a needle into the disc space. The nucleus pulposus of herniated discs were irradiated with laser in order to vaporize a small part of the nucleus pulposus of the intervertebral discs and reduce the voluminosity of diseased discs. Patients were treated with 1000 J of 980 nm diode laser with 5 W energy. In order to measure the severity of pain, visual analog scale (VAS) and also ODI (Oswestry Disability Index) were used. Data were analyzed using SPSS version 12.Results: Thirty patients participated in this trial including 11 men and 19 women with a mean age (SD) of 40.8 (10.8) years. The mean patients VAS score and ODI level before and after discectomy showed statistically significant differences. The mean VAS and ODI scores showed no statistical difference between males and females (P < 0.05) and percutaneous laser discectomy decreased the VAS and ODI at both groups of patients similarly.Conclusion: We found the use of PLDD reduces pain and disability in patients as a noninvasive procedure

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

Catalytic Oxidation of Thiourea at Alumina Modified Pt Electrode

Abstract: Catalytic oxidation of thiourea has been studied at alumina modified Pt electrode using cyclic voltammetry. The results indicate the suitability of alumina modified Pt electrode for voltammetric determination of thiourea. The catalytic peak currents are linearly dependent on the thiourea concentration in the range 2.5 × 10-5 – 7.0 × 10-3 M. The usefulness of the method was tested in determination of thiourea in real samples. Moreover, in this work the heterogeneous electron transfer rate constants of thiourea at the surface of modified and unmodified Pt electrodes were estimated by comparing the experimental cyclic voltammetric responses with the digital simulated results